Cargando…
Emerging Epigenetic and Posttranslational Mechanisms Controlling Resistance to Glucocorticoids in Acute Lymphoblastic Leukemia
Glucocorticoids are extensively used for the treatment of acute lymphoblastic leukemia as they pressure cancer cells to undergo apoptosis. Nevertheless, glucocorticoid partners, modifications, and mechanisms of action are hitherto poorly characterized. This hampers our understanding of therapy resis...
Autores principales: | Borin, Cristina, Pieters, Tim, Serafin, Valentina, Ntziachristos, Panagiotis |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10289758/ https://www.ncbi.nlm.nih.gov/pubmed/37359189 http://dx.doi.org/10.1097/HS9.0000000000000916 |
Ejemplares similares
-
Oncogenic deubiquitination controls tyrosine kinase signaling and therapy response in acute lymphoblastic leukemia
por: Jin, Qi, et al.
Publicado: (2022) -
Gene Mutations Related to Glucocorticoid Resistance in Pediatric Acute Lymphoblastic Leukemia
por: Zhang, JinFang, et al.
Publicado: (2022) -
Dasatinib overcomes glucocorticoid resistance in B-cell acute lymphoblastic leukemia
por: Sarno, Jolanda, et al.
Publicado: (2023) -
Reversal of glucocorticoid resistance in Acute Lymphoblastic Leukemia cells by miR-145
por: Long, Sili, et al.
Publicado: (2020) -
Epigenetic Mechanisms and Posttranslational Modifications in Systemic Lupus Erythematosus
por: Navarro Quiroz, Elkin, et al.
Publicado: (2019)